Integrum resolves on a rights issue of shares of series B of approximately SEK 42.6 million subject to approval by extraordinary general meeting and earlier release of Q2 report

The Board of Directors of Integrum AB (publ) (“Integrum” or the “Company”) has today resolved to carry out a share issue of approximately SEK 42.6 million before deduction of issue costs with preferential rights for existing shareholders (the “Rights Issue”). Integrum is currently undergoing a transformative journey, from a development-driven company to a streamlined and commercially focused organization. The new strategic direction, which was presented in February 2025, aims to accelerate commercialization through a targeted go-to-market model built around Centers of Excellence. Since the launch of the strategy shift, Integrum has taken important steps to streamline operations, sharpen commercial focus and strengthen financial governance. The progression of the strategy shift and the implementation of cost savings are continuing according to plan and the Company has made progress, but the transformation is not yet complete. To support this transformation, Integrum is executing the Rights Issue. The subscription price is SEK 8.0 per share. The Rights Issue is conditional upon approval by an extraordinary general meeting in the Company, scheduled to be held on November 10, 2025. The Rights Issue is covered to 100 percent through subscription commitments and guarantee commitments. The notice to the extraordinary general meeting will be published through a separate press release. Due to the Rights Issue, the Company's board of directors has resolved to publish the Company's Q2 report on November 21, 2025.

Integrum provides update on OsteoCentric’s public offer and provides correction of previous announced information

Mölndal, Sweden, September 18[th], 2025  - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B).  Reference is made to Integrum’s press release published 17 September 2025 at 00:30 CEST, in which Integrum stated it would return to the market as new information becomes available. Today, Integrum can report the following.

Integrum comments on OsteoCentric’s announcement of outcome in the public offer

Mölndal, Sweden, September 17[th], 2025  - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) comments on OsteoCentric’s announcement of outcome in the public offer.

Integrum Unveils Global Marketing Strategy at AOPA National Assembly

Mölndal, Sweden, September 4, 2025 – Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B), the provider of the OPRA™ Implant System, announced the rollout of a new global marketing strategy at the American Orthotic & Prosthetic Association’s (AOPA) National Assembly in Orlando, FL. Central to this initiative is BondedMatrix™ - a coined term designed to capture and convey the OPRA™ Implant System’s distinct ability to integrate soft tissue and bone enabling long-term outcomes to patients, clinicians, and healthcare partners worldwide.

Correction of Figures in Interim Report for the First Quarter 2025/26

When publishing the interim report for the company, it was discovered that some of the total sums in the income statement show the wrong amounts. The sum of Net Sales and Work Performed by Own Use and Activated has mistakenly included Other operating income. Moreover, Other operating expenses was summed erroneously leading to that the sum for Total Expenses showed an incorrect amount. None of the company KPI’s changes from these corrections.

Stronger positioning paves the way for continued growth

First quarter 2025/26 (May – July) · Net sales amounted to SEK 23.8 (18.5) million. · Operating loss totalled SEK 12.4 (12.0) million. · Profit/loss after tax amounted to SEK -10.0 (-9.4) million. · Earnings per share amounted to SEK -0.47 (-0.49) · Cash flow totalled SEK -12.4 (29.3) million. Significant events in the first quarter · In May the company appointed Martin Hillsten as the new CEO. He succeeds interim CEO Scott Flora. · Also in May, the company entered into a commercial distribution agreement with the niche company Labormed d.o.o., which distributes medical equipment for orthopaedic treatments in Slovenia. · In the same month, the company signed an agreement with Bionics Group Ukraine LLC., a specialist in the distribution and integration of medical equipment to hospitals and private clinics in Ukraine. The agreement covers units used in the surgical implantation (S1 and S2 procedures) of the OPRA® Implant System. · In June, the company announced the appointment of Louise Wåhlin as the new Chief Financial Officer. She will assume her new position on 15 September 2025. · In July, the independent bid committee of Integrum AB resolved to recommend that the shareholders of Integrum AB accept the public offer made by OsteoCentric Oncology and Bone Anchored Prostheses, LLC. Significant events after the quarter · After the end of the quarter the company announced that it will assume the role of Legacy Sponsor, the main sponsor, of the Global Collaborative Congress on Osseointegration (GCCO) held annually in Charlotte, North Carolina, USA. GCCO brings together leading professionals to share knowledge, improve outcomes and foster research collaborations in the field of osseointegration. · In August, Integrum AB closed its credit facility of SEK 10 million.

Integrum AB: Invitation to the First Quarter 2025/26 Results Presentation

Mölndal, Sweden – August 28, 2025 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its first quarter 2025/26 results on September 1, 2025 at 10:00 CET.

Integrum secures top sponsorship title at the Global Collaborative Congress on Osseointegration exclusively for the next three years

Mölndal, Sweden, August 13, 2025 – Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B), the provider of the OPRA™ Implant System, has announced that it has secured the exclusive title of Legacy Sponsor – the highest level of sponsorship – for the Global Collaborative Congress on Osseointegration (GCCO) annual meeting, held in Charlotte, North Carolina, USA.

Statement by the independent bid committee of Integrum AB regarding the public takeover offer from OsteoCentric

The independent bid committee of Integrum AB has decided to recommend that the shareholders of Integrum AB accept OsteoCentric Oncology and Bone Anchored Prostheses, LLC’s public takeover offer, based on the evaluation set out below.

Integrum appoints Louise Wåhlin as new Chief Financial Officer

Mölndal, Sweden, June 16[th], 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that Louise Wåhlin has been appointed new Chief Financial Officer. She will take on her new position on September 15[th] 2025.

Integrum terminates agreement with Redeye regarding equity research coverage

Mölndal, Sweden, June 16, 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has terminated the agreement with Redeye regarding equity research coverage.

A rapid shift to full commercial focus

Fourth quarter 2024/25  (February – April) · Net sales amounted to SEK 27.1 m (26.1) · Operating result amounted to SEK -11.7 m (2.6) · Profit/loss after tax amounted to SEK -9.0 m (2.3) · Earnings per share of SEK -0.42 (0.13). · Cash flow for the quarter amounted to SEK 25.0 m (-11.5) Full Year May 2024 –  April 2025 · Net sales amounted to SEK 91.1 m (104.1) · Operating result amounted to SEK -42.4 m (6.5) . · Profit after tax amounted to SEK -30.9 m (4.2) · Earnings per share was SEK -1.45 (0.23). · Cash flow for the period amounted to SEK 22.7 m (-25.0) Significant events during the fourth quarter · In February, the company announced a strategic shift to accelerate the commercialization of OPRA® Implant System and generate cost efficiencies up to SEK 20 m annually. · Similarly in February, Integrum carried out a directed new issue of 1,937,500 series B shares, raising proceeds of approximately SEK 31 million. · In March, the company announced that a newly published independent study from the Walter Reed National Military Medical Center in Bethesda, Maryland, U.S., provides compelling evidence of OPRA®  Implant System’s treatment effectiveness in transfemoral amputees. Significant events after the quarter · After the quarter, the company appointed Martin Hillsten as the new CEO. He succeeds acting CEO Scott Flora, who will continue to support US marketing activities in an advisory capacity and remain on the company’s Board of Directors.

Integrum AB: Invitation to the Fourth Quarter 2024/25 Results Presentation

Mölndal, Sweden – May 30, 2025 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its fourth quarter 2024/25 results on June 3, 2025 at 14:00 CET.

Integrum has signed an agreement with Bionics Group Ukraine LLC to enable a broadened distribution of OPRA® Implant System in Ukraine

Mölndal, Sweden, May 21, 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has entered a distribution agreement with Bionics Group Ukraine, LLC., a niche distributor-integrator of medical equipment for hospitals and private clinics in Ukraine. The agreement covers units that are used in the surgical implantation (S1 and S2 procedures) of the OPRA® Implant System.

Integrum signs commercial distribution agreement with Labormed for the Slovenian market

Mölndal, Sweden, May 19, 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has entered a commercial distribution agreement with Labormed d.o.o., a niche distributor-integrator of medical equipment for orthopaedic treatment clinics in Slovenia. The initial order covers the distribution of OPRA® Implant System units intended for thumb reconstruction surgeries.

Integrum appoints Martin Hillsten as new Chief Executive Officer

Mölndal, Sweden, May 5, 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces the appointment of Martin Hillsten as the new CEO, effective immediately. He succeeds acting CEO Scott Flora, who will continue to support US marketing activities in an advisory capacity and remain on the company’s Board of Directors. Martin Hillsten most recently served as CEO of Integration Diagnostics and has extensive experience in the sales and marketing of advanced medical devices in the US and other parts of the world.

Integrum implements new compensation package for its CEO

Mölndal, Sweden, March 28 2025 — Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has implemented a new compensation package for its Board Director and Acting CEO Scott Flora.

Integrum’s OPRA[TM] Implant System demonstrates superior treatment outcomes in two-year follow-up study by Walter Reed National Military Medical Center

Mölndal, Sweden, March 18, 2025 – Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) announces today that a newly published independent study from the Walter Reed National Military Medical Center in Bethesda, Maryland, U.S., provides compelling evidence of OPRA[TM] Implant System’s treatment effectiveness in transfemoral amputees. The study demonstrates significant functional improvements over traditional socket prostheses, an important validation of Integrum’s innovative technology and its clinical benefit in patients who have undergone amputation.

A strategic shift to accelerate the commercialization of OPRA® Implant System

Third quarter 2024/25 (November – January) · Net sales amount to 23.7 (30.1) MSEK. · Operating result amounts to -7.4 (0.3) MSEK. · Profit/loss after tax amounted to -3.5 (0.8) MSEK, which resulted in earnings per share of SEK -0.18 (0.04). · Cash flow from operating activities amounts to -5.0 MSEK (1.0) 1 May 2024 – 31 January 2025 (9 months) · Net sales amounted to 64.0 (78.1) MSEK · Operating result amounted to -30.7 (3.9) MSEK. · Profit after tax amounted to -21.9 (1.9) MSEK, which resulted in earnings per share of SEK -1.13 (0.10). · Cash flow from operating activities amounts to -25.1 (5.2) MSEK. Significant events in the third quarter · In November Integrum announced the launch of a new service initiative to enhance warranty and service support for its Axor™ II devices. · After Patric Lindgren resigned from the board, an extra general meeting was held in January, in which Anette Lindqvist and Kristofer Westergren joined Integrum AB as new board members. · Similarly in January, the company announced that it will, in collaboration with SPS, co-host seven regional educational events for CPOs across the United States in the coming months. Significant events after the quarter · After the quarter, the company announced a strategic shift to accelerate the commercialization of OPRA® Implant System and generate cost efficiencies up to SEK 20 million annually. · In February the company successfully completed a directed share issue of 31 MSEK.

Integrum AB: Invitation to the Third Quarter 2024/25 Results Presentation

Mölndal, Sweden – February 27, 2025 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its third quarter 2024/25 results on March 3, 2025 at 14:00 CET.

Integrum explores the conditions to carry out a directed new issue of series B shares of approximately SEK 30 million

Mölndal, Sweden – 18 February 2025 – The Board of Directors of Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) (“Integrum” or the “Company”) has engaged Carnegie Investment Bank AB (publ) (“Carnegie”) to evaluate the conditions for carrying out a directed share issue of series B shares amounting to approximately SEK 30 million (the “Share Issue”) through an accelerated bookbuilding process, which commences immediately.

Integrum has carried out a directed new issue of 1,937,500 series B shares, raising proceeds of approximately SEK 31 million

Mölndal, Sweden – 18 February 2025 – The Board of Directors of Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) (“Integrum” or the “Company”) has resolved to conduct a directed new issue of 1,937,500 B-shares at an issue price of 16 SEK per B-share (the “Share Issue”). The issue price has been determined through an accelerated bookbuilding procedure carried out by Carnegie Investment Bank AB (publ) (“Carnegie”).

Integrum implements strategic shift to accelerate the commercialization of OPRA® Implant System and generate cost efficiencies up to SEK 20 million annually

Mölndal, Sweden – February 18, 2025 - Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces a strategic shift to accelerate market penetration of the OPRA® Implant System. The strategy includes focusing on selected centers of excellence, strengthening the aftermarket business, and introducing a new Key Performance Indicator (KPI) to enhance transparency. Additionally, Integrum will streamline operations to generate cost efficiencies up to SEK 20 million annually when fully implemented in the beginning of 2026. To optimize shareholder value, the Board is also evaluating a potential separation of the long-term R&D pipeline.

Integrum publishes preliminary revenue, result and cash flow figures for Q3, 2024/2025

Mölndal, Sweden – February 18, 2025 —Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today publishes its preliminary revenue, operating profit and cash flow figures for Q3 and May-January 24/25.

Integrum Partners with SPS to Expand 2025 Education Calendar, Enhancing Learning Opportunities

Integrum, ticker INTEG, the leader in innovative bone-anchored prosthetic solutions, is proud to announce the expansion of their 2025 Education Calendar. In collaboration with Southern Prosthetic Supply (SPS), the leading U.S. distributor of orthotic and prosthetic (O&P) products, and other leading prosthetic manufacturers, Integrum will co-host seven regional educational events across the United States in the coming months. These events will provide prosthetists with knowledge of the OPRA™ Implant System and how it integrates into their clinical practices to provide a solution for their transfemoral amputee patients who struggle with or are expected to struggle with the use of traditional sockets.

Integrum welcomes new board members

Integrum AB (publ), ticker INTEG, the medical technology company that provides the bone-anchored OPRA implant system to amputees, welcomes the new board members Kristofer Westergren and Anette Lindqvist elected on the Extra General Meeting.

Integrum partners with Intelerad to Streamline Surgical Planning and Enhance Patient Outcomes in the US

Integrum AB (publ), ticker INTEG, the medical technology company that provides the bone-anchored OPRA® Implant System to amputees, partners with Intelerad to Streamline Surgical Planning and Enhance Patient Outcomes

The nomination committee in Integrum plans to propose the election of Anette Lindqvist as board member at an extraordinary general meeting

Integrum AB (publ), short name INTEG, the medical technology company that provides the bone-anchored OPRA™ Implant System to amputees, announces that the election committee of Integrum plans to propose the election of Anette Lindqvist as board member at an extra general meeting . Board member Patric Lindgren has informed the election committee that he has resigned from the board on December 18. Notice of the extraordinary general meeting will be issued shortly.

Enhanced Commercial Focus Leads to Rebound in Stage One Surgeries in the US

Second quarter 2024/25 (August – October) · Net sales amount to 21.8 (27.6) MSEK, which is a decrease of 21.0 % compared with the corresponding period last year. The growth in the US market and in Rest of the World is -23 % and -14 % compared with the corresponding period last year, respectively. · Operating result amounts to -11.3 (6.5) MSEK. The operating result amounted to -10.5 MSEK excluding currency effects of -0.8 MSEK, most of which are unrealized internal accounts receivables. · Profit/loss after tax amounted to -8.9 (3.9) MSEK, which resulted in earnings per share of SEK -0.46 (-0.22). · Cash flow from operating activities amounts to -9.5 MSEK (6.8), change in working capital was 1.0 MSEK (-1.2) and investing activities -3.3 (-2.0). Total cash flow was -12.0 (3.4) MSEK. Liquid assets as of 2024-10-31 amount to 34.1 (33.3) MSEK, not including 31.6 MSEK in accounts receivables. Significant events in the quarter · The board announced that Scott Flora, board member since 2023, was appointed acting CEO of Integrum AB after Rickard Brånemark left the role and was appointed Chief Scientific Advisor. · The first OPRA® Implant System procedure was done in the UK. · Ty Hanners was appointed Director of Sales, US, focused on expanding the OPRA surgical system product offering to amputees. 1 May 2024 – 31 October 2024 (6 months) · Net sales amounted to 40.2 (48.0) MSEK, a decrease of 16.1 % compared with the corresponding period in the previous year. The growth in the US market and in the Rest of the World is -11.4 % and -16.5 % compared with the corresponding period last year, respectively. · Operating result amounted to -23.2 (3.5) MSEK. The operating result amounted to -21.1 MSEK excluding currency effects of -2.1 MSEK, most of which are unrealized internal accounts receivables. · Profit after tax amounted to -18.4 (1.0) MSEK, which resulted in earnings per share of SEK -0.95 (0.06). · Cash flow from operating activities amounts to -20.0 (4.2) MSEK. Total cash flow was 17.2 (-8.6) MSEK. Significant events in the year · Integrum carried out an issue of 961,539 new series B shares, at a subscription price of SEK 52 per share, raising proceeds of approximately SEK 50 million. · The company has finalized a trade term loan facility agreement of about 24 MSEK as an option to finance its accounts receivables · Integrum announced that the company has received market approval for the OPRA® Implant System in Israel.

Integrum AB: Invitation to the Second Quarter 2024/25 Results Presentation

Mölndal, Sweden – November 29, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its second quarter 2024/25 results on December 4, 2024 at 14:00 CEST.

Integrum Launches Service Initiative to Strengthen U.S. Market Growth

Integrum AB (publ), ticker INTEG, a leader in medical technology and developer of the bone-anchored OPRA® Implant System, announces the launch of a new service initiative to enhance warranty and service support for its Axor™ II devices. This initiative is a critical step in advancing Integrum’s expansion in the U.S. market and driving sustainable growth.

Osseointegration for Amputees Makes its Education Forum Debut at OTA 2024

Integrum AB (publ), ticker INTEG, the medical technology company that provides the bone-anchored OPRA® Implant System to amputees announces its education forum debut.

Ty Hanners appointed Director of Sales, US, focused on OPRA Implant System for Amputees

Integrum AB (publ), ticker INTEG, the medical technology company that provides the bone-anchored OPRA implant system to amputees, announces that Ty Hanners has been appointed Director of Sales, US, focused on expanding the OPRA surgical system product offering to amputees. He will start on October 14, 2024.

Join Us for an Investor Update Online with our Acting CEO Scott Flora

Integrum AB (publ), the medical technology company that improves the lives of amputees, cordially invites you to an online investor information session on September 25, 2024, @ 3 pm CEST.

Inger Rydin is appointed interim COO and takes office immediately

Integrum AB (publ), the medical technology company that improves the lives of amputees, announces that Inger Rydin has been appointed interim COO and will be responsible for operations at the office in Mölndal, Sweden. Inger, who served as interim COO at Integrum from 2021 to 2023, will be part of the management team. She takes office immediately.

The board of Integrum appoints Scott Flora as acting CEO

Integrums CEO Rickard Brånemark has today agreed together with the board that he will leave the CEO role. The board announces that Scott Flora, board member since 2023, has been appointed acting CEO of Integrum AB. He takes office with immediate effect. The board will immediately start the recruiting process of a new CEO. Rickard Brånemark is appointed Chief Scientific Advisor.

Focus on long-term growth creates setback in sales

FIRST QUARTER 2024/25 (MAY – JULY) · Net sales amounted to 18.5 (20.4) MSEK, which is a decrease of 9.5% compared with the corresponding period last year. · Operating profit amounted to -12.0 (-2.9) MSEK. The operating result amounted to -10.6 MSEK excluding currency effects of -1.4 MSEK, most of which are unrealized internal accounts receivables. · Profit/loss after tax amounted to  -9.4 (-2.9) MSEK, which resulted in earnings per share of SEK -0.49 (-0.1). · Cash flow from operating activities amounts to -10.5 MSEK (-2.6), change in working capital was -3.5 MSEK (-7.1) and investing activities -2.6 (-1.9). Total cash flow was 29.3 (-12.1) MSEK. Liquid assets as of 2024-07-31 amount to 46.2 (29.9) MSEK, not including 33.7 MSEK in accounts receivables.   Significant events in the quarter · Integrum entered a commercial collaboration and distribution agreement with Hanger, the leading provider of amputee care and prosthetics in the US that delivers care to almost one-third of all amputees in the country. · Integrum carried out an issue of 961,539 new series B shares, at a subscription price of SEK 52 per share, raising proceeds of approximately SEK 50 million. · The company has finalized a trade term loan facility agreement of about 24 MSEK as an option to finance its accounts receivables. · The company signed a Memorandum of Understanding with Coapt LLC, with the intention to provide Integrum the possibility to combine Coapt’s pattern recognition technology with the continued development of e-OPRA® Implant System. · Integrum announced that the company has received market approval for the OPRA® Implant System in Israel.

Integrum AB: Invitation to the First Quarter 2024/25 Results Presentation

Mölndal, Sweden – August 26, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) will host a webcast presentation of its first quarter 2024/25 results on August 29, 2024 at 14:00 CEST.

Integrum has carried out a directed new issue of 961,539 series B shares, raising proceeds of approximately SEK 50 million

Mölndal, Sweden – 13 June 2024 – Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) (“Integrum” or the “Company”) has successfully carried out an issue of 961,539 new series B shares, at a subscription price of SEK 52 per share, raising proceeds of approximately SEK 50 million (the “Directed Issue”).

Integrum intends to carry out a directed new issue of series B shares of approximately SEK 50 million

Mölndal, Sweden – 13 June 2024 – Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) (“Integrum” or the “Company”) announces its intention to carry out an issue of series B shares of approximately SEK 50 million directed to Swedish and international institutional investors (the “Directed Issue”). Integrum has appointed Carnegie Investment Bank AB (publ) (“Carnegie”) as Sole Global Coordinator and Bookrunner to explore the conditions to carry out the Directed Issue through an accelerated book-building procedure.

Instructional Course:  OPRA™ Implant System

The course will be held, live and in person, in Gothenburg, Sweden, on Sept 28th 2023. Please note, the deadline for registration is Sept 12th. Meeting address GoCo House (conference room: Marie Curie), Entreprenörsstråket 10, 431 53 Mölndal, Sweden Time Sept 28th, 8:45-17:00 CET Key Speakers Final program will be sent 2 weeks prior to […]

SVT Documentary; Robothanden

In this documentary, a research participant is followed to get a thought-controlled prosthetic hand. It is life-changing and shows how Integrum’s technology can contribute to the improved function of prosthetics. See documentary

Integrum's e-OPRA™ Implant System highlights in the Swedish national public service television News "Aktuellt," a more extensive coverage is in the Swedish TV show "Ask the Doctor," and there is an article and clip in the Swedish TV Online newsroom.

The Swedish national public service television interviews Tonney Forsberg, an amputee, and Max Ortiz Catalàn, former head of R&D at Integrum, and now a professor in bionics (a mix between biology and electronics).  Max talks about the new possibilities opening up by combining osseointegration and AI, a result from the collaboration between Integrum, Chalmers University of […]

Meet Kerstin Caine-Winterberger, among the first occupational therapists in the world specialized in rehabilitation with osseointegration for upper limb patients

In a recent interview, Kerstin Caine-Winterberger described her more than 40 years´ clinical experience in the rehabilitation of upper limb amputees, and the dramatic impact that the introduction of bone-anchored prostheses has made on her patients’ quality of life. As an occupational therapist, Kerstin’s focus has been the rehabilitation of hand injuries and amputations of […]

Integrum hosted a technical workshop on the clinical advantages of the OPRA™ Implant System and how it helps patients lead more active lives at the AAOP (American Academy of Orthotists and Prosthetists) annual meeting and scientific symposium

May 4th – 7th the AAOP held its annual meeting and scientific symposium (virtually) in New Orleans, Louisiana. During the meeting, Integrum hosted a technical workshop for prosthetists and orthotists from around the world. Presenters during the workshop were Kurt Collier, Certified Prosthetist and VP of Prosthetics at Integrum, Kevin Symms, Certified Orthotist, and amputee […]

Integrum’s industrial PhD student Alexander Thesleff successfully defends his doctoral thesis “Neuromusculoskeletal interfacing of lower limb prostheses“ at Chalmers University of Technology, Gothenburg, Sweden

On May 27th, Alexander Thesleff received his Ph.D. from the Department of Electrical Engineering, Chalmers University for his research regarding the connection of a leg prosthesis with the skeleton, muscles, and the nerves. Alexander received an Industrial Ph.D. based on his research performed in collaboration with Chalmers and Integrum, for his investigation of the challenges […]

Rickard Brånemark interviewed by Innovativa Företag (Innovative Companies)

In their latest issue, Innovativa Företag, a magazine focusing on the most innovative companies in Sweden, interviewed Professor Rickard Brånemark. The magazine is published online, and is distributed in print with Svenska Dagbladet, which is Sweden’s 3rd largest daily newspaper. It reaches approximately half a million readers. During the interview, Professor Brånemark describes the journey […]

Per-Ingvar Brånemark, honored by the inauguration of Global Osseointegration Day

  May 3rd, 2021, marks the first Global Osseointegration Day, a day which posthumously honors Professor Per-Ingvar Brånemark, who is regarded around the world as the “father” of osseointegration. Global Osseointegration Day will take place every year, on May 3rd, Professor Per-Ingvar Brånemark’s birthday. Read about the event Global Osseointegration Day Professor Brånemark’s pioneering work […]

Göteborgs Posten interviews Ulf Karlsson, one of five persons in Sweden to have received Integrum’s e-OPRA™ Implant System

Göteborgs Posten, the largest newspaper in Western Sweden, interviewed Ulf Karlsson regarding the impact which the unique e-OPRA™ Implant System has had on his life. This unique treatment, developed through a research collaboration between Chalmers University of Technology, Sahlgrenska University Hospital, and Integrum AB, allows Ulf to communicate directly between his brain and his prosthesis. […]

Dagens Industri, Invest Talks, interviews Rickard Brånemark, founder and chairman, regarding Integrum’s virtual monopoly in the multi-billion dollar market in the US

With almost half a million daily readers, Dagens Industri is Sweden’s largest financial newspaper. Their independent Investor Relations platform, Invest Talks, which interviews coporate leaders of listed companies, interviewed founder and chairman, Rickard Brånemark regarding the recent PMA (premarket approval) for the OPRA™️ Implant System received from the FDA in the US, and its implications […]

Prosthetist shares the dramatic impact of Integrum’s OPRA™ Implant System

Mike Corcoran—Prosthetist specializing in hip disarticulation, hemipelvectomy, and care of wounded warriors Mike Corcoran is the co-founder of Medical Center Orthotics and Prosthetics (MCOP), based in Silver Spring, Maryland, near Washington, D.C. As a prosthetist with 31 years’ experience of practicing prosthetics, and 5 years’ experience of designing and developing artificial limbs to be used […]

Integrum exhibiting at Hanger Live 2021

Integrum is proud to announce our participation at the Hanger Live, Powered by Purpose, meeting held February 4th-5th, 2021. This virtual educational event allows all 4900 Hanger clinical care providers from across the US to participate and gain valuable insight into the latest developments within O&P (Orthotic and Prosthetic) patient care. Hanger Inc, provides O&P […]

Forbes features research with Integrum’s e-OPRA™ Implant System

The digital platform of Forbes Media, Forbes.com, which reaches over 20 million unique visitors each month, featured research from Dr. Max Ortiz Catalán, Chalmers University of Technology, Gothenburg, Sweden observing patients treated with Integrum’s e-OPRA™ Implant System.   Latest research on the e-OPRATM Implant System In the Forbes.com article “People with Bionic Hands Can’t Correct […]

Dr. Rickard Brånemark and Magnus Niska Interviewed on TV4 Nyhetsmorgon, Saturday, December 19th

On Saturday morning, Dr. Rickard Brånemark, founder of Integrum AB, and Magnus Niska, the first patient in the world treated with Integrum’s revolutionary e-OPRATM Implant System, were interviewed by journalist Jenny Strömstedt, on the very popular TV show, Nyhetsmorgon, on channel 4 in Sweden. During the interview, Dr. Brånemark described this unique and revolutionary treatment, […]

Trevor Noah Podcast: Dr. Max Ortiz Discusses Bionic Limbs and Prosthetic Technology

In the Trevor Noah Podcast episode: Your Robot Brain, Dr. Max Ortiz Catalán explains that the communication gap that once lay between the most advanced prostheses and their users is, thanks to his research and collaboration with Integrum, now bridged. It is now possible to truly connect the brain and the prosthesis, and thereby achieve […]

Magnus Niska of Team e-OPRA won bronze medal at Cybathlon 2020 with Integrum's thought-control bionic arm

Team e-OPRA, a collaborative team made up of professionals from Integrum AB, Chalmers University of Technology, and Sahlgrenska University Hospital, faced fierce competition from all over the world at the Cybathlon 2020. Two athletes (also known as pilots) from Team e-OPRA representing Sweden—Magnus Niska and Tonney Forsberg—participated in the discipline “Power Arm Prosthetic Race“. This […]

TV4 interviews Magnus Niska, as he prepares to compete with his bionic arm in the Cybathlon 2020 Global Edition

Every four years, athletes with disabilities from all over the world participate in Cybathlon, competing in one of several disciplines. This year, due to the global pandemic, athletes or so-called “pilots” gathered online at each team’s home base. Magnus is competing in the discipline “Powered-Arm Prosthesis Race” with Tonney Forsberg. They are guided by Team e-OPRA […]

Giant Step Forward on Artificial Legs

Watch this special segment from CBS Sunday Morning, where Donna and Carol describe how, after receiving osseointegration treatment, their lives have been completely transformed. Where they have previously been confined indoors and condemned to an inactive lifestyle due to their socket prostheses, they are once again able to pursue an active life outdoors; walking, gardening […]

The Mind-Controlled Prosthetic Arm : Integrum’s e-OPRA™ Implant System at the CYBATHLON 2020

The CYBATHLON is an international multi-sport event in which contestants with physical disabilities compete using the most advanced technical assistance systems. The competition aims to promote and drive the continuous development and exchange of knowledge within assistive technology. Also known as Cyborg Olympics, CYBATHLON is held every four years. The second CYBATHLON takes place on […]

Integrum presents the OPRA™ Implant System at the American Association of Nurse Life Care Planners, AANLCP

The American Association of Nurse Life Care Planners (AANLCP) is the premier professional member organization of nurses and non-nurses working in the field of life care planning. The AANLCP promotes education, collaboration, exchange of knowledge and research, and the establishment of industry standards in Nurse Life Care Planning. Nurse Life Care Planning in the US […]

Biostock Studio: Integrum has a monopoly situation in the U.S. market

Swedish Integrum AB has developed the only FDA approved method for treating amputees with bone-anchored prostheses. In an interview with Biostock, Rickard Brånemark, founder and Chairman of the Board at Integrum AB, describes the head start that the company has as being alone in the U.S. market for the next 3-5 years; a market which […]

In Conversation With Biostock:- On Integrum's Leading Position in the Bone-Anchored Prosthesis Industry

In an article published on October 13th, 2020, Biostock interviewed James Sheridan, Head of Sales and Marketing, EMEA, APAC at Integrum AB, and Patrick Treacy, CEO at Onkos Surgical. The article outlines Integrum’s leading position in the bone-anchored prosthetics market, the commercial breakthrough through its framework agreement with the US Military, the Pre-market Approval application […]

Integrum’s Co-Founder and Chairman of the Board, Professor Rickard Brånemark, interviewed by Biostock

In an article titled ‘Integrum awaits an important milestone on the road to commercial breakthrough‘ published August 2020, Biostock interviews Professor Rickard Brånemark, co-founder and Chairman of the Board.  The interview touches upon the history of Integrum with the discovery of Osseointegration and dental implant technology. It visits several milestones for the company, such as […]

Integrum exhibiting at the Amputee Coalition 2020 National Conference

Join us on August 19-22 at the Amputee Coalition 2020 National Conference!  Integrum is happy to announce our participation at the Amputee Coalition virtual 2020 National Conference held between August 19-22.   The American Amputee Coalition is a non-profit organization dedicated to enhancing the quality of life for amputees and their families through support, education about […]

Integrum’s e-OPRA™ Implant System is Restoring Touch in Prosthetic Arms

Advances in robotics are paving the way towards prostheses with functionalities similar to their biological counterparts. While the state-of-the-art prostheses are now capable of mimicking fine movements and grips, the level of intuitive control and sensory feedback individuals with amputation have with their prostheses are still primitive.   Researchers recently published the capabilities of our osseointegrated […]

Clinical Research Quantifies Loads for Osseointegrated Lower Limb Prostheses

Prosthesis acceptance is a major determinant of people’s quality of life after amputation. Along with factors such as phantom limb pain, misaligned expectations for prosthesis, psychological adjustment and functionality, prosthetic socket issues are a primary reason for prosthesis rejection. Compression and friction forces imposed by the prosthetic socket on the skin of the residual limb […]

Reuters features Integrum's e-OPRA™ Implant System

Reuters features Integrum’s e-OPRA™ Implant System The e-OPRA™ Implant System is one of the most advanced prosthetic systems in the world with intuitive control and sensory feedback. The technology is developed upon the OPRA™ Implant System– our bone-anchored prostheses system based on osseointegration.  The clinical report demonstrating the long-term performance of the e-OPRA™ Implant system […]

University Medical Center Groningen at the Forefront of Translating Phantom Limb Pain Research into Clinical Care with Neuromotus™

The University Medical Center Groningen   As one of the largest hospitals in the Netherlands and the largest employer in the Northern Netherlands, the University Medical Center Groningen (UMCG) focuses on care, education, training, and research. The UMCG not only provides patient-centered care but also aims to conduct revolutionary scientific and educational research on healthy ageing to build the […]

Bo Håkansson, a pioneer in osseointegration research, rewarded honorary doctorate at the Sahlgrenska Academy.

Bo Håkansson is a professor of Electrical Engineering at the Chalmers University of Technology. He is the pioneering researcher in bone-anchored hearing implants. His work resulted in the translation and development of commercially available osseointegrated hearing aids that have positively impacted the lives of several thousands of people worldwide. The appointment by the Board of […]

OPRA™ Implant System – Transforming the World of Prosthetics

ABC 12 News features Osseointegration with the OPRA™ Implant System ABC 12 News, a news channel in Michigan, featured the OPRA™ Implant System and the technology of Osseointegration on their segment HealthSource. Watch the video here. They interviewed Munya Mahiya, who recently shared his story on WMC5 Action News, highlighting Osseointegration and the OPRA™ Implant […]

Integrum and Onkos Surgical hold second educational seminar on Osseointegration

Integrum and Onkos Surgical hosted their second online educational symposium recently on the surgical and prosthetic technologies used with the OPRA™ Implant System. The symposium was attended by 30 participants from 15 institutions. We thank all the participants and look forward to continued collaborative work The collaboration between Integrum and Onkos Surgical is focused on […]

Job Opening: Head of Sales and Marketing EMEA

Integrum AB is seeking to hire an executive to lead its Sales and Marketing organization.  The individual will oversee Integrum’s product portfolio:  OPRATM Implant System – a revolutionary surgical technology that allows amputees to be set free from the confines of a traditional socket-based prosthesis and Neuromotus – an innovative solution for the treatment of […]

e-OPRA™ recipient shares his perspective on TV4 news

The Ideal Replacement for a Biological Hand The conclusions of the clinical study on the efficacy and performance of the e-OPRA™ system was published recently in the New England Journal of Medicine. One of the recipients of the e-OPRA™ system. Rickard Normark, shared his perspective on  TV 4, a Swedish news channel. Watch the interview […]

A Near Bionic Prosthetic-The OPRA™ Implant System

A Near Bionic Prosthetic Munya Mahiya, a UC Berkeley Alumnus and a wheelchair basketball player for the Golden State Road Warriors, has recently shared his story and postoperative experience with the OPRA™ Implant System on WMC Action News 5. The OPRA Implant system is a bone-anchored prosthesis system that allows the prosthesis to be skeletally […]

Onkos Surgical & Integrum Co-Hosts Educational Session On Osseointegration

With the spread of the pandemic and consequent restrictions on traveling the American Academy of Orthopaedic Surgeons Annual Meet 2020 in Florida was canceled where Integrum and Onkos Surgical had planned their inaugural presentation after the partnership announcement in January 2020. The collaboration between Integrum and Onkos Surgical is focused on expanding the US market […]

Dr.Max Ortiz Catalan receives the Chalmers Foundation Award 2020

Dr. Max Ortiz Catalan receives the Chalmers Foundation Award for 2020 for his work on natural control of prostheses through osseointegrated implants. CHALMERS FOUNDATION The Foundation’s motivation for the award is as follows: “The Chalmers Foundation was formed in 1994, with the task of supporting Chalmers to carry out research and education at a high […]

Dr. Brånemark to present at University of Maryland

Dr.Brånemark will present a Seminal Research lecture on Osseointegration at the University of Maryland on 28th February.  He will share the groundbreaking advances within osseointegration and limb restoration as well as the latest research. Despite the advances in prosthesis and sockets, there is a high rejection rate of socket prosthesis among people with amputation. For […]

Milestones in Amputation Care at University Medical Center Göttingen

University Medicine Göttingen(UMG) positions itself at the forefront of orthopedic surgery in Germany with the completion of its first Osseointegrated and Targeted Muscle Reinnervation (TMR) surgery last year. Osseointegration for amputees refers to the anchoring the prosthesis directly through the bone. This treatment is becoming a widely acceptable and beneficial alternative for those who have […]

Alfred Hospital-Establishing Holistic Amputee Care Management in Australia

In  October 2019, Alfred Hospital conducted their fourth workshop on Osseointegration for Bone Anchored prosthesis with the OPRA Implant system and Target Muscle Reinnervation (TMR) at the Regional Medical Australian and New Zealand Society (RMANZ). Pioneering Osseointegration in Australia The Alfred Hospital is the largest and most active Trauma Service in Australasia. They treat over […]

Henry Wallman 2019 Award Cermony

  In June 2019, the Stiftelsen Medicin och Teknik at Chalmers announced Dr. Rickard Brånemark, Dr. Max Ortiz Catalan and Kerstin Hagberg as the receipients of the 2019 Henry Wallman Award. The award recognizes their work within osseointegrated neural controlled prosthetics (e-OPRA). Our press release published 26 June 2019 describes more about the the work that […]

Event Recap: Osseointegration at 2019 NEAAOP Conference 

Developments in Osseointegration The benefits of osseointegration for both upper and lower limb amputees has been well recognized and documented in numerous peer reviewed clinical studies.  In June of 2015 the FDA provided an HDE approval (Humanitarian Device Exception) for use of the OPRA System (Osseointegrated Prosthesis for Rehabilitation of Amputees) for transfemoral amputees.  Work […]

Inside Walter Reed: The Future of Prosthetics

NBC4 News aired a segment on ‘Inside Walter Reed:The Future of Prosthetics‘ on October 8th’ 2019. The program features the OPRA Implant System from Integrum. News4’s Doreen Gentzler talks about her visit to Walter Reed National Military Medical Center at Bethesda, Washington. During the visit, she learned about the clinical trial evaluating Osseointegration as a […]

Upcoming Event: Dr. Ortiz holding Keynote Lecture at ISPO World Congress 2019

International Society for Prosthetics and Orthotics (ISPO) Kobe, Hyogo Japan 5-8th October 2019 Kyobe, Hyogo Japan is hosting the 17th International Society for Prosthetics and Orthotics (ISPO) World Congress between 5-8th October 2019.   ISPO is a global non-profit organization working towards improving the quality of life for people with reduced mobility. This is done by […]

Integrum on 'Voice of Industry'-ORTHOWORLD

ORTHOWORLD® is a provider of strategic intelligence focussed on the global orthopaedic market. Their mission is to help orthopaedic companies and individuals improve their performance. They featured an interview with Magnus René on the success of the OPRA™ osseointegrated prosthetic implant system. Magnus René is the former President and CEO of Arcam and member of […]

Upcoming Event: OPRA Insight Forum Series: Chapter Orlando

The OPRA Insight Forum Series is a set of outreach programs hosted by Integrum held across the U.S. to help educate and inform the limb loss community about Osseointegration. The forums are designed to provide a broad perspective on Osseointegration and specifically the OPRA Implant System. A review of the acceptance criteria for consideration, brief […]

Upcoming Event: OPRA™ Insight Forum Series: Chapter Boston

The OPRA Insight Forum Series is a set of outreach programs hosted by Integrum held across the U.S. to help educate and inform the limb loss community about Osseointegration. The forums are designed to provide a broad perspective on Osseointegration and specifically the OPRA Implant System. A review of the acceptance criteria for consideration, brief […]

Patient completes 20 year check up with OPRA™ Implant System

Erik Ax, 79 years old, is one of the earliest recipients of the OPRA™ Implant System. Erik is an above-knee amputee who was having several problems with his prosthetic socket.As a result, he sought out Integrum to receive an osseointegrated bone-anchored prosthesis. He had his osseointegration surgery in 1999 and is now having his implant […]

Upcoming Event: Clinical Assessment for Osseointegration Patients in London, UK

London International Patient Services (LIPS) is hosting a clinical assessment session with Mr.Culpan and Prof. Brånemark on Sept 13, 2019. At this session, Prosthesists or Orthosists with patients interested in Osseointegration and amputees will have the opportunity to get a clinical assessement for osseointegration with the OPRA Implant System. The session will be held at […]

Upcoming Event: 20th Annual Meeting of ISOLS, 2019

Athens, Greece will be hosting the 20th Annual Meeting of International Society of Limb Salvage (ISOLS). The ISOLS is a platform where experts in the field of musculoskeletal oncology and limb salvage techniques come together to promote intellectual exchange in research, surgical techniques, education and clinical practice in the discipline. Dr. Rickard Brånemark will be […]

Celebrating 10 years of Osseointegration in Chile.   Pioneering Osseointegration in Latin America. 

On Aug 20th,  Hospital del Trabajador-Chile hosted the Congress of Osseointegration 2019 in commemoration of 10 years of Osseointegration in Chile. Hospital del Trabajador are the pioneers in the region and the only center providing osseointegration in Latin America.   Over 90 participants from a mixed population of surgeons, healthcare providers, physiotherapists, occupational therapists and amputees […]

INTEGRUM TO INAUGURATE OPRA INSIGHT FORUM SERIES

In conjunction with the company’s ongoing expansion in the US, Integrum will inaugurate the OPRA Insight Forum Series with its first chapter in Charlotte, North Carolina, USA on August 27TH, 2019. The OPRA Insight Forum Series is a set of outreach programs hosted by Integrum held across the U.S. to help educate and inform the […]

Celebrating 10 years of Osseointegration in Chile . Pioneering Osseointegration in Latin America.

We are glad to celebrate 10 years of experience in osseointegration with our collaboration team in Chile during the Congress of Osseointegration in Hospital del Trabajador- Chile, which will be held on August 20, 2019. The convention will provide healthcare providers, patients and the community with information on osseointegration with the OPRA Implant System, its […]

Congratulations to UCSF on being ranked among Best Hospitals in USA.

US News recognizes UCSF Medical Center as one the leading hospitals in the country with 10 departments in the top 10 centers nationwide in their U.S. News & World Report’s 2019-2020. The orthopaedics department has been ranked 4th nationwide. Integrum congratulates UCSF on their continued recognition as one of the most prestigious hospitals in the […]

Best Wishes for the Summer Holidays!

Congratulations Dr Enzo Mastinu!

We are proud to announce that our colleague Enzo Mastinu has successfully defended his PhD thesis, “Towards clinically viable neuromuscular control of bone-anchored prosthetic arms with sensory feedback” at Chalmers University of Technology.   Dr. Mastinu has pursued his PhD in a joint collaboration between Integrum AB and Chalmers University of Technology, developing an embedded system for intuitive control of a […]

Meet Integrum at FEESH,17-21st of June in Berlin, Germany!

We are pleased to announce that Integrum will participate at the FEESH meeting 17-21 st of June 2019 in Berlin, Germany. Integrum will be present in the booth at Pohlig GmbH. During the meeting the technology of osseintegration for finger/thumb and arms will be shown. In January 2019 a new study was published to be […]

COME VISIT US AT VITALIS 2019 Integrum will be presenting at Vitalis (Booth B06:71)

Vitalis is the largest eHealth event in Scandinavia. The event is visited by many key individuals, organizations and companies operating in the Nordic countries. A growing number of delegates from outside the Nordics are also attending.

Prof R Brånemark is a selected speaker and will give a lecture at Klinikum der Universität München, Germany, 18th of September.

Next week, 18th of September 2018, Prof Rickard Brånemark who is a selected speaker at the Klinikum der Universität München, will give a lecture on Osseointegrated Implants in prosthetic extremity reconstructions- Interfacing in the 21st century. Flyer_SL_Branemark_2018-07-11

Rick Cicero, transfemoral and transhumeral amputee and recipient of Integrum’s OPRA Implant System.

  Rick Cicero KVOA News 4 Tucson AZ July 16th, 2018   Rick Cicero, transfemoral and transhumeral amputee and recipient of Integrum’s OPRA system at both levels shares his life changing experiences on the local news channel in Tucson, Arizona during the Annual Amputee Coalition Conference.  He is providing a presentation to the rehabilitation specialist […]

Association of Orthotist and Prosthetist of America

The 2018 National Assembly will be held September 26-29 in Vancouver, BC, Canada—An expected 2,500 attendees from over 40 different countries are expected to attend.  A larger booth, #1212, with two OPRA patients present will increase our presence and help to strengthen the brand.  Lastly, Dr. Branemark’s presentation during the Future Possibilities in Amputation Surgery […]

Meet us at 2nd International Symposium on Innovations in Amputation Surgery and Prosthetic Technologies meeting (IASPT) May 9-12th 2018 in Vienna!

 We are pleased to announce that Integrum will participate at the  2nd International Symposium on Innovations in Amputation Surgery and Prosthetic Technologies meeting (IASPT) May 9-12th 2018 in Vienna, Austria. Please visit us and meet with some of Integrums product users, medical professionals and Integrum staff. You are very welcome to find us in our booth.  […]

Meet us at EMSOS 9-11 th of May in Amsterdam!

Meet us at EMSOS 9-11 th of May in Amsterdam! We are pleased to announce that Integrum will participate at the EMSOS (European Musculo-Skeletal Oncology Society) meeting 2018 May 10-11 in Amsterdam, Netherlands. Please visit us and meet with some of Integrum’s product users and Integrum staff. You are very welcome to find us in booth 2.

OPRA™ bone anchored prosthesis now available in London

The unique OPRA™ Implant System from Integrum, who improves the quality of life for patients by eliminating the need for a conventional socket prosthesis, is now provided by London International Patient Services (LIPS) your connection to London’s top consultants. For more information please click on this link: IntegrumLIPS    

Meet us at the OTWorld 15th-18th of May 2018 in Leipzig!

We are pleased to announce that Integrum will participate at the OTWorld 2018 May March 15-18th in Leipzig. Please visit us and meet with some of Integrums product users, medical professionals and Integrum staff. You are very welcome to find us in booth D01b Hall 5. During the OTWorld meeting Integrum will also invite for […]

Meet us at the AAOS 2018 Annual Meeting!

We are pleased to announce that Integrum will participate at the American Academy of Orthopaedic Surgeons (AAOS) 2018 Annual Meeting March 6-10 in New Orleans, Louisiana, USA. Please visit us and meet with some of Integrums product users, medical professionals and Integrum staff. You are very welcome to find us in booth 1013. Meeting Location: […]

US Army Soldiers are fitted with Integrum’s OPRA Implant System

Integrums collaboration with the US Department of Defense is showing good progress and several patients have started the rehabilitation phase. The osseointegration program is led by the work of Navy Commander (Dr.) Jonathan Forsberg and Army Lieutenant colonel (Dr.) Kyle Potter. Please click on the link to experience some of the great achievements https://www.youtube.com/watch?v=eS4O99lLgrY&feature=youtu.be   […]

Integrum is included in the magazine inMotion for the limb loss community

The award-winning publication inMotion is written by healthcare professionals, leaders in the limb loss community and those affected by limb loss. Integrum is proud to be part in the inMotion magazine and hope that more individuals with limb loss will recognize the benefits of bone anchored prosthesis. Please klick on the link for the full […]

Integrum was recognized by the French President Emmanuel Macron and Stefan Löfven

Integrum had the honor to meet the President of France and the Swedish Prime Minister this Friday evening. Very honorable that Integrum is recognized at this event and we hope that it will enable us to reach out to more people in France. Check out the last 6 minutes of the video link: https://www.facebook.com/EmmanuelMacron/videos/2062784580620784/

2-day instructional course in osseointegration

Save the date 15-16th Nov 2017  Integrum invites medical professionals to participate in a 2-day instructional course for the OPRA Implant System for thumb/finger, humerus and femur in November 2017. The course will give the professionals an introduction to osseointegration and the OPRA Implant System. The attendees will have the opportunity to meet with experienced […]

The US Department of Defense offers amputees a revolutionary new option in prosthesis

<!–Notes ACF –> Integrums collaboration with the US Department of Defense has good progress and some patients have already initiated the treatment using Integrums OPRA Implant System. The osseointegration program at Walter Reed Walter Reed National Military Medical Center (WRNMMC) began in 2016. The osseointegration program is led by the work of Navy Cmdr. (Dr.) […]

Integrum's first delivery to Ottobock in the United States

The first delivery of Integrum prosthetic components to Ottobock has been carried out in the United States. This marks the start of Integrum’s collaboration with Ottobock Healthcare. The order represents a strategically important milestone since Ottobock can start to sell & market Integrum’s products on the US market. “We are very proud to collaborate with […]

Nasdaq Stockholm welcomes Integrum to First North

Nasdaq (Nasdaq: NDAQ) announces that the trading in Integrum AB’s shares (short name: INTEG B) commenced today on Nasdaq First North in Stockholm. Please read more here

Winner of the Blatchford Award 2017

Integrum collaborators have been awarded for outstanding record of innovative achievement in the field of prosthetics and/or orthotics. The Blatchford Award 2017 has been presented to the multidisciplinary team of surgeons, physiotherapists, occupational therapists, and prosthetists from Sahlgrenska University Hospital (SUH), as well as researchers from Chalmers University of Technology (CTH) and University of Gothenburg […]

Nasdaq First North IPO May 15th

Integrum has talking the steps to be a listed company on Nasdaq First North. We have reached several milestones in the listing process and the date is set to be May 15 as the introduction date. This will enable several advantages for Integrum and we will be able to provide additional resources for development, marketing […]

Integrum and Ottobock Partner for the Benefit of Amputees

Integrum has entered a collaboration with Ottobock in the field of osseointegration regarding distribution of prosthetic connection elements related to Integrum’s OPRA implant system. Integrum is thrilled to collaborate with Ottobock, the market leader in prosthetics, to distribute Integrum’s prosthetic components in the US. This is a major step forward in developing Integrums presence in […]

Integrum surgical course in San Diego, March 12-13, 2017

The University of California San Francisco (UCSF) and the Orthopaedic Surgical Osseointegration Society (OSOS) are arranging the 7th international conference about Advances in Orthopaedic Osseointegration. Several Integrum co-workers will participate and share some of our latest developments. Integrum will arrange a surgical course at the conference. Please read more here  

A new stronger OPRA Implant System is launched

Integrum is introducing the OPRA Implant System Platform G to be used for transfemoral patients. The new platform is CE labeled and approved by the FDA and will be available in January 2017. The OPRA Implant System Platform G improves the mechanical performance of the system, simplifies the surgical procedure and enhances osseointegration. Please contact […]

A revolutionary phantom limb pain treatment

Neuromotus is a revolutionizing technology to relieve Phantom Limb Pain. The technology has been proven in a clinical trial with good results. The results have recently been published in the medical journal The Lancet. The technology is in the final stage of development. Please read more at our new product website Neuromotus.se and sign up […]

UCSF Medical Center performs Osseointegration crowdfunding campaign

UCSF Medical Center is planning to treat several Transfemural (above the knee) patients on a yearly basis. Apart from hospital expenses, patients traveling from across the nation will have to find resources to cover the cost of lodging and travel in order to have the first clinical screening, as well as surgery and aftercare. UCSF […]

Integrum’s Research Director, Dr. Max Ortiz Catalán is the winner of the 14th Annual Delsys Prize

Dr. Max Ortiz Catalán winning proposal, titled “Myoelectric pattern recognition and augmented reality for the treatment of Phantom Limb Pain”, was selected from a field of 134 entries from 29 countries. The entries represented a remarkably broad range of interests in diverse areas as Biomechanics, Exercise Physiology, Signal Processing, Facial EMG, Robotics, Rehabilitation, and various […]

Sweden wins medal in the Cybathlon competition, “cyborg Olympics”, at the Swiss Arena in Zürich

The first recipient of our osseointegration and neural control technology competed on 8 October in the Cybathlon, an event aimed at pushing the technological boundaries to reduce disability. More than 8,000 spectators and 700 journalists covered this initial event. Despite being the only participant with an above-elbow amputation, a disadvantage when competing against below-elbow-amputees, the […]

The first US surgery has successfully been performed at UCSF

UCSF Medical Center in San Francisco is the first U.S. center to proceed with an OPRA program. This unique program gives amputees new hope for better prosthesis. The historic first U.S. surgery with the Integrum OPRA System took place last week. The patient receiving the implant is a 54-year-old man who lost most of his right leg due to […]

Kerstin Hagberg in the latest issue of “Fysioterapi”

Physiotherapist Kerstin Hagberg, associate professor at the Centre of Orthopaedic Osseointegration (COO) at Sahlgrenska University Hospital, is in the latest issue of the Swedish magazine “Fysioterapi”. In the article, you can read about Kerstin’s work and how the OPRA Implant system has change the life for a young Swedish man. Read the article here (Swedish)

Dr. Brånemark featured speaker at IAA Conference

The founder of Integrum, Dr. Rickard Brånemark , is one of the featured speakers at the 30th Annual meeting of the International Anaplastology Association to be held June 1-4, 2016 in Dallas/Fort Worth, Texas. Take the opportunity to listen to Dr. Brånemark and his presentation “Osseointegration for Orthopedic Applications” on 2 June at 2.05 pm. Read […]

News report

ABC 7 News have done a news report about the OPRA Implant System that is currently being tested at the University of California, San Francisco. The report can be read here

Orthotic and Prosthetic Innovation & Technology Symposium

Dr. Rickard Brånemark, founder of Integrum, is one of the featured speakers at the 6th Orthotic and Prosthetic Innovation & Technology Symposium which is held on the 6th of November in the Milberry Union Event & Meeting Center in San Francisco. You can read more about the symposium here

Article in Göteborgs-Posten

The Swedish Newspaper Göteborgs-Posten, the biggest daily morning paper in the west of Sweden, published an article about Integrum. The article describes how Integrum will enter the US market and also briefly describes conventional products compared to bone anchored prostheses. The article can be read here (in Swedish)

Article in Dagens Industri

The Swedish newspaper Dagens industri, Scandinavia’s largest business newspaper, has published an article about Integrum. The article relates to Integrum being the first company in the world with bone anchored prosthesis to be approved by the FDA for use in the U.S. The article can be read here (in Swedish)

The OPRA Implant System is FDA approved

The U.S. Food and Drug Administration (FDA) has of today, July 16th 2015, announced that the humanitarian device exemption (HDE) for Integrum´s OPRA Implant System is approved. The approval provides an unprecedented opportunity to improve the life for several thousands of individuals living with limb loss in the United States. Integrum is the first company […]

Swedish Medtech week

Integrum was part of the Swedish Medtech week hosted by the Association for Medical Technology in Sweden. Integrum presented the company and demonstrated some of the latest research. This was an event for national and regional officials and politicians aiming to raise awareness and create a conversation about medical technology. You can read more about […]

Conference of the International Graphonomics Society

Dr. Max Ortiz Catalan from Integrum will give a keynote speech at the 17th Conference of the International Graphonomics Society on Monday 22th of June. You can read more about it here 

A big thank you

A big thank you to everyone who participated in the Prosthetic course last week. We appreciate the feedback and it was nice to see everyone.

the Shanghai Symposium on Neural-Machine Interfacing

Dr. Max Ortiz Catalan from Integrum will be giving a talk at the Shanghai Symposium on Neural-Machine Interfacing on June 16th. The talk will be about his neuromuscular interface that allows for mind controlled prosthetics that is based on the OPRA Implant System

The Centre of Advanced Reconstruction of Extremities

The Centre of Advanced Reconstruction of Extremities (C.A.R.E.) at Sahlgrenska University Hospital is inaugurated on Friday the 22th of May. Integrum will be present as will some of the patients using the OPRA system.

Meet us at AAOS Annual Meeting!

We are pleased to announce that Integrum will participate at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in Las Vegas, March 25-27, 2015. You are very welcome to find us in booth number 664. See more here.

Göteborgs-Posten

The Swedish newspaper Göteborgs-Posten, has a piece on a patient treated with the OPRA Implant System. The treatment has helped the patient return to his job as an optician and has improved his quality of life. The piece can be read here (in Swedish).

Presentation

CEO of Integrum and associate professor at Sahlgrenska University Hospital, Dr. Rickard Brånemark and Dr. Max Ortiz Catalan presented their work in mind-controlled prosthetics to the Swedish Minister of Enterprise, Mikael Damberg. The Swedish news paper, Dagens Industri, did a report that can be read here (In Swedish, requires subscription, but a free try-out period is available)

Watch the TEDxGöteborg-talk

In November, Dr. Max Ortiz Catalan from Integrum gave a talk at TEDxGöteborg about his mind controlled prosthetics that are based on the OPRA Implant System. The talk can be watched here

Watch the Spanish talkshow

Dr. Max Ortiz Catalan from Integrum participated in the Spanish talkshow El Hormiguero together with 2 patients. The show can be streamed here (in Spanish). Integrums effort into mind controlled prosthetics is considered the 7th most important research project by the Swedish Dagens Medicin. Their report can be read here (in Swedish).

Participating in the Spanish talkshow El Hormiguero

Dr. Max Ortiz Catalan from Integrum will participate in the Spanish talkshow El Hormiguero together with Magnus Niska, who is the first patient using OPRA with neuromuscular electrodes and Irene Villa, who is a bilateral amputee using the OPRA implant system. The program is broadcasted on Spanish Antena 3 TV the 10th of December at […]

Interview with Magnus Niska

Magnus Niska, the first patient using OPRA with neuromuscular electrodes, was interviewed in the Swedish talkshow “Malou efter tio”. The interview can be seen here (in Swedish).

TEDxGöteborg

Dr. Max Ortiz Catalan from Integrum will give a talk at TEDxGöteborg the 18th of November about his mind controlled prosthetics that are based on the OPRA implant system. More information about the talk can be found here

Interview with Dr. Rickard Brånemark

CEO of Integrum and associate professor at Sahlgrenska University Hospital, Dr. Rickard Brånemark, is interviewed by Reuters about the mind-controlled prosthetic arm, that has been made possible with the next generation of the OPRA system. The report can be seen here.

The first patient using OPRA™ with implanted neuromuscular interfaces is revealed.

The future for the OPRA™ system is presented today, as the first patient using OPRA™ with implanted neuromuscular interfaces is revealed. The system has been used by the patient since January 2013. This breakthrough is the result of a collaboration between Integrum, Chalmers University of Technology and Sahlgrenska University Hospital. The official press release can […]

Lecture by Max Jair Ortiz Catalan

Max Jair Ortiz Catalan from Integrum will give a short lecture on future control of arm and leg prosthetics at the National Life Science Day. The event takes place at Skogshem & Wijk, Lidingö on the 30th of September and the lecture will be at 11:20. Read more about it here.

Study from Chalmers University of Technology

In February this year, a study from Chalmers University of Technology, that was supported by Integrum, that demonstrated a novel treatment for phantom limb pain (PLP) was published. The treatment successfully reduced the pain levels for a chronic PLP patient, for whom no other treatments had been successful. A multi-centre clinical trial verifying the results from this […]

Lecture by Dr. Todd Kuiken

Dr. Todd Kuiken from the Rehabilitation Institute of Chicago is giving a lecture on Developing Neural Interfaces for Robotic Prostheses at Chalmers Wednesday the 11th of June at 15:00-16:00.  The lecture is taking place at the EC-room, EDIT-building at Hörsalsvägen 11

Vetenskapsfestivalen

Researchers from Integrum will participate in Vetenskapsfestivalen (The Science Festival) in Gothenburg Friday the 9th of May to present research in naturally controlled prosthetics. Research engineers Morten Bak Kristoffersen and Alejandra Zepeda will have a presentation followed by a 2-hour demonstration at 13:00 in Nordstan and research engineer Max Ortiz Catalan will  give a lecture at 19:30 […]

Vinnova

Integrum just received 5 out of 65 million SEK for innovative small and medium sized companies from Vinnova. The funding is for further development in osseointegrated nerve and muscle controlled prosthetics with sensory feedback. The press release from Vinnova can be read here (in Swedish)

Presentation

Dr. Örjan Berlin will do a oral presentation titeled An osseointegrated percutaneous prosthetic system for the treatment of patients with transfemoral amputation: Results from the OPRA technique at EMSOS 2014 Friday the 23rd of Maj.

Björn Rydevik talks about osseointegrated amputation prostheses

On Friday March 7, at the Swedish Embassy in Tokyo, Professor Björn Rydevik will talk about osseointegrated amputation prostheses. Click here for more information.

A new study

A new study from Chalmers University of Technology and the Center of Orthopaedic Osseointegration on the treatment of phantom limb pain (PLP) has been published today. The study presents a novel treatment that has successfully reduced the pain levels for a chronic PLP patient for whom other treatments have not worked. The study has been […]

Prospective clinical study

The first prospective clinical study of 51 patients treated with an osseointegrated prosthetic system for transfemoral amputation is published in the Bone and Joint Journal. The study presents a cumulative survival rate of 92% at two years combined with enhanced prosthetic use and mobility, fewer problems and improved quality of life, which supports the ‘revolutionary […]

The main feature

Christoffer Lindhe, who is a trilateral amputee with two fixtures osseointegrated into the bones, is the main feature in the newest edition of Ingenjören (eng. The Engineer). The article is about his accident, life and his work to bring his own prosthetic foot to the market. The article is available here (pdf, page 25).

A new team

The new team at Centro Hospitalar do Porto in Portugal has performed their first surgery with the OPRA Implant System. We welcome Dr. Cantista, Dr. Cardoso, Dr. Oliviera and their team and look forward to our future collaboration.